HEALTHCARE PR: Global preference
27 Sep 2002 | by MARY COWLETT
Drug firms are boosting their reputations by preferential pricing, writes Mary Cowlett.
PRWeek's first ever roundtable on healthcare PR drew leading industry figures - from both agencies...ble debate for the healthcare PR sector comes at a time when the industry is witnessing great ...
Drug firms are boosting their reputations by preferential pricing, writes Mary Cowlett.
Nick Purdom reports on one of the few mature direct to consumer healthcare PR markets....and services,' explains Johnstone. The DTC debate continues while healthcare PR practitioners in the ...
After a year-long debate, Nick Purdom examines the implications of the EC review on DTC and finds that while reform is necessary, critics contend the proposals are inadequate.